These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33082287)

  • 1. Interclass GPCR heteromerization affects localization and trafficking.
    Toneatti R; Shin JM; Shah UH; Mayer CR; Saunders JM; Fribourg M; Arsenovic PT; Janssen WG; Sealfon SC; López-Giménez JF; Benson DL; Conway DE; González-Maeso J
    Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-Specific Incorporation of Genetically Encoded Photo-Crosslinkers Locates the Heteromeric Interface of a GPCR Complex in Living Cells.
    Shah UH; Toneatti R; Gaitonde SA; Shin JM; González-Maeso J
    Cell Chem Biol; 2020 Oct; 27(10):1308-1317.e4. PubMed ID: 32726588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
    Moreno JL; Holloway T; Albizu L; Sealfon SC; González-Maeso J
    Neurosci Lett; 2011 Apr; 493(3):76-9. PubMed ID: 21276828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. His452Tyr polymorphism in the human 5-HT
    Martín-Guerrero SM; Alonso P; Iglesias A; Cimadevila M; Brea J; Loza MI; Casado P; Martín-Oliva D; Cutillas PR; González-Maeso J; López-Giménez JF
    Biochem Pharmacol; 2021 Mar; 185():114440. PubMed ID: 33539816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of DOM-Induced Head-Twitch Response by mGluR2 Agonist/Inverse Agonist is Associated with 5-HT
    Gao H; Liu X; Xie L; Tan B; Su R
    Neurochem Res; 2024 Mar; 49(3):636-648. PubMed ID: 37989895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function.
    Moreno JL; Muguruza C; Umali A; Mortillo S; Holloway T; Pilar-Cuéllar F; Mocci G; Seto J; Callado LF; Neve RL; Milligan G; Sealfon SC; López-Giménez JF; Meana JJ; Benson DL; González-Maeso J
    J Biol Chem; 2012 Dec; 287(53):44301-19. PubMed ID: 23129762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crosstalk between 5-HT
    Saha S; González-Maeso J
    Neuropharmacology; 2023 Jun; 230():109489. PubMed ID: 36889432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons.
    Wang MJ; Li YC; Snyder MA; Wang H; Li F; Gao WJ
    PLoS One; 2013; 8(4):e61787. PubMed ID: 23593498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGI proteins can differentially regulate the signaling pathways of 5-HT
    Hammad MM; Dunn HA; Ferguson SSG
    Cell Signal; 2018 Jul; 47():109-121. PubMed ID: 29625175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.
    Moreno JL; Miranda-Azpiazu P; García-Bea A; Younkin J; Cui M; Kozlenkov A; Ben-Ezra A; Voloudakis G; Fakira AK; Baki L; Ge Y; Georgakopoulos A; Morón JA; Milligan G; López-Giménez JF; Robakis NK; Logothetis DE; Meana JJ; González-Maeso J
    Sci Signal; 2016 Jan; 9(410):ra5. PubMed ID: 26758213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDZK1/NHERF3 differentially regulates corticotropin-releasing factor receptor 1 and serotonin 2A receptor signaling and endocytosis.
    Walther C; Caetano FA; Dunn HA; Ferguson SS
    Cell Signal; 2015 Mar; 27(3):519-31. PubMed ID: 25562428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a serotonin/glutamate receptor complex implicated in psychosis.
    González-Maeso J; Ang RL; Yuen T; Chan P; Weisstaub NV; López-Giménez JF; Zhou M; Okawa Y; Callado LF; Milligan G; Gingrich JA; Filizola M; Meana JJ; Sealfon SC
    Nature; 2008 Mar; 452(7183):93-7. PubMed ID: 18297054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of mGluR
    Nuara SG; Gourdon JC; Maddaford S; Huot P
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Dec; 394(12):2381-2388. PubMed ID: 34550406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of Akt.
    Schmid CL; Streicher JM; Meltzer HY; Bohn LM
    Neuropsychopharmacology; 2014 Jul; 39(8):1902-13. PubMed ID: 24531562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cells.
    Baki L; Fribourg M; Younkin J; Eltit JM; Moreno JL; Park G; Vysotskaya Z; Narahari A; Sealfon SC; Gonzalez-Maeso J; Logothetis DE
    Pflugers Arch; 2016 May; 468(5):775-93. PubMed ID: 26780666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT
    Murat S; Bigot M; Chapron J; König GM; Kostenis E; Battaglia G; Nicoletti F; Bourinet E; Bockaert J; Marin P; Vandermoere F
    Mol Psychiatry; 2019 Nov; 24(11):1610-1626. PubMed ID: 29858599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptor 2 and corticotrophin-releasing factor receptor-1 gene expression is differently regulated by BDNF in rat primary cortical neurons.
    Jørgensen CV; Klein AB; El-Sayed M; Knudsen GM; Mikkelsen JD
    Synapse; 2013 Nov; 67(11):794-800. PubMed ID: 23766023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.
    Muguruza C; Miranda-Azpiazu P; Díez-Alarcia R; Morentin B; González-Maeso J; Callado LF; Meana JJ
    Neuropharmacology; 2014 Nov; 86():311-8. PubMed ID: 25150943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
    Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
    Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.